A Meta-Analysis of Randomized Controlled Trials Comparing Chemotherapy Plus Trastuzumab with Chemotherapy Alone in HER-2-Positive Advanced Breast Cancer

被引：6
|
作者：
Liao, Cun [1 ]
Yin, Fang [1 ]
Huang, Ping [1 ]
Cao, Yunfei [1 ]
Gao, Feng [1 ]
机构：
[1] Guangxi Med Univ, Affiliated Hosp 1, Dept Colorectal & Anal Surg, Nanning, Guangxi, Peoples R China
来源：
BREAST JOURNAL | 2011年 / 17卷 / 01期
关键词：
PHASE-II TRIAL; PACLITAXEL; THERAPY;
D O I：
10.1111/j.1524-4741.2010.01034.x
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：109 / 111
页数：3
相关论文
共 50 条
  • [31] Efficacy of gemcitabine-based chemotherapy in metastatic breast cancer: a meta-analysis of randomized controlled trials
    Li, Weibing
    Wang, Hongbiao
    Li, Xuyuan
    CURRENT MEDICAL RESEARCH AND OPINION, 2013, 29 (11) : 1443 - 1452
  • [32] Randomized Phase II Study of Primary Systemic Chemotherapy and Trastuzumab for Operable HER2 Positive Breast Cancer
    Nakamura, Seigo
    Ando, Masashi
    Masuda, Norikazu
    Aogi, Kenjiro
    Ino, Hiroyo
    Iwata, Hiroji
    Tokuda, Yutaka
    Yamamoto, Naohito
    Kasai, Hiroi
    Takeuchi, Masahiko
    Tsuda, Hitoshi
    Akiyama, Futoshi
    Kurosumi, Masafumi
    Fujiwara, Yasuhiro
    CLINICAL BREAST CANCER, 2012, 12 (01) : 49 - 56
  • [33] Gemcitabine and S-1 combination chemotherapy versus gemcitabine alone for locally advanced and metastatic pancreatic cancer: a meta-analysis of randomized controlled trials in Asia
    Li, Yanxun
    Sun, Jinjin
    Jiang, Zhijia
    Zhang, Linqiang
    Liu, Geng
    JOURNAL OF CHEMOTHERAPY, 2015, 27 (04) : 227 - 234
  • [34] Trastuzumab-induced cardiotoxicity in elderly women with HER-2-positive breast cancer: a meta-analysis of real-world data
    Leung, Henry W. C.
    Chan, Agnes L. F.
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (11) : 1661 - 1671
  • [35] Neoadjuvant pyrotinib plus trastuzumab and chemotherapy for HER2-positive breast cancer: a prospective cohort study
    Liu, Lu
    Zhu, Mingzhi
    Wang, Yanyan
    Li, Muhan
    Gu, Yuanting
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2023, 21 (01)
  • [36] Dose-dense weekly chemotherapy in advanced ovarian cancer: An updated meta-analysis of randomized controlled trials
    Marchetti, C.
    De Felice, F.
    Di Pinto, A.
    D'Oria, O.
    Aleksa, N.
    Musella, A.
    Palaia, I.
    Muzii, L.
    Tombolini, V.
    Panici, P. Benedetti
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2018, 125 : 30 - 34
  • [37] Efficacy and safety of taxanes combined with chemotherapy drugs in advanced triple negative breast cancer: A meta-analysis of 26 randomized controlled trials
    Huang, Qionglian
    Mei, Zubing
    Han, Xianghui
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [38] Effects of chemoradiotherapy and chemotherapy on survival of patients with locally advanced pancreatic cancer A meta-analysis of randomized controlled trials
    Wang, Cuiying
    Liu, Xiaohua
    Wang, Xiaohua
    Wang, Yanlei
    Cha, Na
    MEDICINE, 2018, 97 (36)
  • [39] Short-duration versus 1-year adjuvant trastuzumab in early HER2 positive breast cancer: A meta-analysis of randomized controlled trials
    Chen, Lujia
    Zhou, Wenqi
    Hu, Xiaolei
    Yi, Man
    Ye, Changsheng
    Yao, Guangyu
    CANCER TREATMENT REVIEWS, 2019, 75 : 12 - 19
  • [40] Is it safe to give anthracyclines concurrently with trastuzumab in neo-adjuvant or metastatic settings for HER2-positive breast cancer? A meta-analysis of randomized controlled trials
    Du, Feng
    Yuan, Peng
    Zhu, Wenjie
    Wang, Jiayu
    Ma, Fei
    Fan, Ying
    Xu, Binghe
    MEDICAL ONCOLOGY, 2014, 31 (12) : 1 - 9
12345